Alectinib (lung cancer drug) suppresses COVID-19 virus replication via SRPK (serine/arginine-rich protein kinase), our favorite RNA kinase. Our small contribution to this amazing work by Tomer and others, is now on bioRxiv! Also see our previous study about SRPK2.